Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

58.49%

Threshold

Crossed downwards

Timeline

Published

17.03.2021

Transaction

09.03.2021

Voting rights breakdown

Voting rights acquired3.51%
Voting rights sold58.49%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAL3F00044

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

acquisition and disposal of shares on March 9, 2021; also regarding certain sales positions

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open